EFFECT OF ENDOTHELIAL PROGENITOR CELLS IN PROMOTING OSTEOGENESIS OF TISSUE ENGINEERED BONE IN VIVO_Chinese Journal of Reparative and Reconstructive Surgery

Authors：

WULi ¹ , ZHAOXian ² , HEBo ¹ , CHENZegu ³ , LULin ¹ , WEIHanxiao ² , ZHANGChenglei ⁴ ,  LIULiu ²

1. Department of Medical Imaging, the First Affiliated Hospital, Kunming Medical University, Kunming Yunnan, 650032, P. R. China;
2. Department of Plastic Surgery, the First Affiliated Hospital, Kunming Medical University, Kunming Yunnan, 650032, P. R. China;
3. Department of Radiology, Affiliated Haikou Hospital, Xiangya School of Medicine, Central South University;
4. Department of Vascular Surgery, the First Affiliated Hospital, Kunming Medical University, Kunming Yunnan, 650032, P. R. China;

Corresponding?author：

LIULiu, Email: liuliu3939@126.com

Keywords：

Endothelial progenitor cells; Bone marrow mesenchymal stem cells; Neovascularization; Tissue engineered bone; Rabbit

DOI：

10.7507/1002-1892.20160020

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the ability of autologous peripheral blood endothelial progenitor cells (EPCs) in promoting neovascularization of tissue engineered bone and osteogenesis of bone marrow mesenchymal stem cells (BMSCs). Method The peripheral blood EPCs and BMSCs from No. 1-9 New Zealand rabbits were isolated, cultured, and identified. According to the cell types, the third generation of cells were divided into 3 groups:EPCs (group A), BMSCs (group B), and co-cultured cells of EPCs and BMSCs (group C, EPCs:BMSCs=1:2) . Then cells were seeded on the partially deproteinised bone (PDPB) packaged with fibronectin to construct tissue engineered bone. After 4 days, autologous heterotopic transplantation of tissue engineered bone was performed in the rabbit's muscles bag of groups A, B, and C (the right arm, left arm, right lower limb respectively, 2 pieces each part). At 2, 4, and 8 weeks after transplantation, the growth of tissue engineered bone was observed, and the rate of bone ingrowth was calculated by HE staining; the expressions of CD34, CD105, and zonula occludens protein 1(ZO-1) were compared by immunohistochemical staining at each time point in tissue engineered bone among 3 groups. Results The EPCs and BMSCs were isolated and identified successfully; immunofluorescent staining showed that EPCs were positive for CD34, CD133, and von Willebrand factor (vWF), and BMSCs were positive for CD29 and CD90 and were negative for CD34. The tissue engineered bone constructed in 3 groups was transplanted successfully. At 2, 4, and 8 weeks after autologous heterotopic transplantation, the general observations showed that the soft tissue around the tissue engineered bone increased and thickened gradually in each group with time passing; the boundary between bone and soft tissue was not clear; the pore space of tissue engineered bone gradually was filled, especially in group C, the circuitous vascular network could be seen in the tissue engineered bone. HE staining showed capillaries and collagen fibers increased gradually, tissue engineered bone ingrowth rate was significantly higher in group C than groups A and B at 4 and 8 weeks (P<0.05) , and group B was significantly higher than group A (P<0.05) . Immunohistochemical staining showed that the expressions of CD34, CD105, and ZO-1 in tissue engineered bone of 3 groups all increased with the extension of time, showing significant differences between groups at each time point (P<0.05) . At 2 weeks after transplantation, the expression of CD105 in group C was significantly higher than that in groups A and B (P<0.05) ; at 4 and 8 weeks, CD34, CD105, and ZO-1 expressions showed significant differences between 2 groups (P<0.05) ; the expression was the highest in group C, and was the lowest in group B. Conclusions Autologous peripheral blood EPCs and BMSCs have synergistic effect, and can promote neovascularization and osteogenesis of tissue engineered bone in vivo.

Citation： WULi, ZHAOXian, HEBo, CHENZegu, LULin, WEIHanxiao, ZHANGChenglei, LIULiu. EFFECT OF ENDOTHELIAL PROGENITOR CELLS IN PROMOTING OSTEOGENESIS OF TISSUE ENGINEERED BONE IN VIVO. Chinese Journal of Reparative and Reconstructive Surgery, 2016, 30(1): 95-101. doi: 10.7507/1002-1892.20160020 Copy

1.	Li Q, Wang Z. Influence of mesenchymal stem cells with endothelial progenitor cells in co-culture on osteogenesis and angiogenesis:an in vitro study. Arch Med Res, 2013, 44(7) :504-513.
2.	Schumann P, Lindhorst D, von See C, et al. Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel. J Biomed Mater Res A, 2014, 102(6) :1652-1662.
3.	Yamada A, Yokoo T, Yokote S, et al. Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats. Hum Cell, 2014, 27(2) :59-67.
4.	王福科,劉流,李彥林,等.骨髓基質干細胞與PDPB體外構建組織工程骨的適宜條件.中國組織工程研究與臨床康復, 2008, 12(33) :6401-6405.
5.	趙嫻.自體外周血EPCs與BMSCs聯合PDPB構建微血管化生物骨.昆明:昆明醫科大學, 2013.
6.	幸嶸,孔清泉,項舟,等.小鼠干細胞成骨和成軟骨分化特異性微小RNA的初步研究.中國修復重建外科雜志, 2014, 28(8) :1009-1016.
7.	晏開力,汪健,李慶,等.成人骨髓間充質干細胞分化為血管內皮細胞的研究.中國修復重建外科雜志, 2007, 21(1) :76-80.
8.	Song X, Liu S, Qu X, et al. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1. Acta Biochim Biophys Sin (Shanghai), 2011, 43(10) :796-804.
9.	Lindhorst D, Tavassol F, von See C, et al. Effects of VEGF loading on scaffold-confined vascularization. J Biomed Mater Res A, 2010, 95(3) :783-792.
10.	Martin JR, Gupta MK, Page JM, et al. A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species. Biomaterials, 2014, 35(12) :3766-3776.
11.	Ebrahim NA, Leach L. Temporal studies into attachment, VE-cadherin perturbation, and paracellular migration of human umbilical mesenchymal stem cells across umbilical vein endothelial monolayers. Stem Cells Dev, 2015, 24(4) :426-436.
12.	王偉,劉德紅,李卓成,等.轉染VEGF基因對內皮祖細胞生長的影響研究.中國實驗診斷學, 2015, 19(3) :355-358.
13.	Menge T, Gerber M, Wataha K, et al. Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway. Stem Cells Dev, 2013, 22(1) :148-157.
14.	Nassiri SM, Rahbarghazi R. Interactions of mesenchymal stem cells with endothelialcells. Stem Cells Dev, 2014, 23(4) :319-332.
15.	Huang S, He P, Peng X, et al. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs. Cell Physiol Biochem, 2015, 37(1) :253-268.
16.	Su CH, Wu YJ, Chang CY, et al. The increase of VEGF secretion from endothelial progenitor cells post ultrasonic VEGF gene delivery enhances the proliferation and migration of endothelial cells. Ultrasound Med Biol, 2013, 39(1) :134-145.
17.	Xue J, Du G, Shi J, et al. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction. Chin Med J (Engl), 2014, 127(9) :1677-1683.
18.	Raida M, Heymann AC, Günther C, et al. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med, 2006, 18(4) :735-739.
19.	He X, Dziak R, Yuan X, et al. BMP2 genetically engineered MSCs and EPCs promote vascularized bone regeneration in rat critical-sized calvarial bone defects. PLoS One, 2013, 8(4) :e60473.
20.	溫麗.血管內皮祖細胞對大鼠骨髓間充質干細胞生物學特性調控作用的研究.西安:第四軍醫大學, 2013.
21.	Pusztaszeri MP, Seelentag W, Bosman FT, et al. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem, 2006, 54(4) :385-395.

1. Li Q, Wang Z. Influence of mesenchymal stem cells with endothelial progenitor cells in co-culture on osteogenesis and angiogenesis:an in vitro study. Arch Med Res, 2013, 44(7) :504-513.
2. Schumann P, Lindhorst D, von See C, et al. Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel. J Biomed Mater Res A, 2014, 102(6) :1652-1662.
3. Yamada A, Yokoo T, Yokote S, et al. Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats. Hum Cell, 2014, 27(2) :59-67.
4. 王福科,劉流,李彥林,等.骨髓基質干細胞與PDPB體外構建組織工程骨的適宜條件.中國組織工程研究與臨床康復, 2008, 12(33) :6401-6405.
5. 趙嫻.自體外周血EPCs與BMSCs聯合PDPB構建微血管化生物骨.昆明:昆明醫科大學, 2013.
6. 幸嶸,孔清泉,項舟,等.小鼠干細胞成骨和成軟骨分化特異性微小RNA的初步研究.中國修復重建外科雜志, 2014, 28(8) :1009-1016.
7. 晏開力,汪健,李慶,等.成人骨髓間充質干細胞分化為血管內皮細胞的研究.中國修復重建外科雜志, 2007, 21(1) :76-80.
8. Song X, Liu S, Qu X, et al. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1. Acta Biochim Biophys Sin (Shanghai), 2011, 43(10) :796-804.
9. Lindhorst D, Tavassol F, von See C, et al. Effects of VEGF loading on scaffold-confined vascularization. J Biomed Mater Res A, 2010, 95(3) :783-792.
10. Martin JR, Gupta MK, Page JM, et al. A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species. Biomaterials, 2014, 35(12) :3766-3776.
11. Ebrahim NA, Leach L. Temporal studies into attachment, VE-cadherin perturbation, and paracellular migration of human umbilical mesenchymal stem cells across umbilical vein endothelial monolayers. Stem Cells Dev, 2015, 24(4) :426-436.
12. 王偉,劉德紅,李卓成,等.轉染VEGF基因對內皮祖細胞生長的影響研究.中國實驗診斷學, 2015, 19(3) :355-358.
13. Menge T, Gerber M, Wataha K, et al. Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway. Stem Cells Dev, 2013, 22(1) :148-157.
14. Nassiri SM, Rahbarghazi R. Interactions of mesenchymal stem cells with endothelialcells. Stem Cells Dev, 2014, 23(4) :319-332.
15. Huang S, He P, Peng X, et al. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs. Cell Physiol Biochem, 2015, 37(1) :253-268.
16. Su CH, Wu YJ, Chang CY, et al. The increase of VEGF secretion from endothelial progenitor cells post ultrasonic VEGF gene delivery enhances the proliferation and migration of endothelial cells. Ultrasound Med Biol, 2013, 39(1) :134-145.
17. Xue J, Du G, Shi J, et al. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction. Chin Med J (Engl), 2014, 127(9) :1677-1683.
18. Raida M, Heymann AC, Günther C, et al. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med, 2006, 18(4) :735-739.
19. He X, Dziak R, Yuan X, et al. BMP2 genetically engineered MSCs and EPCs promote vascularized bone regeneration in rat critical-sized calvarial bone defects. PLoS One, 2013, 8(4) :e60473.
20. 溫麗.血管內皮祖細胞對大鼠骨髓間充質干細胞生物學特性調控作用的研究.西安:第四軍醫大學, 2013.
21. Pusztaszeri MP, Seelentag W, Bosman FT, et al. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem, 2006, 54(4) :385-395.

Previous Article
EFFECT OF SIMULATED IN VIVO PHYSIOLOGICAL ENVIRONMENT SEVERED LIMB FOSTERING SYSTEM APPLYING REMOTE ISCHEMIC CONDITIONING PERFUSION ON PRESERVING SEVERED LIMB

Chinese Journal of Reparative and Reconstructive Surgery

EFFECT OF ENDOTHELIAL PROGENITOR CELLS IN PROMOTING OSTEOGENESIS OF TISSUE ENGINEERED BONE IN VIVO

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content